BR112017007942A2 - sistemas de liberação - Google Patents

sistemas de liberação

Info

Publication number
BR112017007942A2
BR112017007942A2 BR112017007942A BR112017007942A BR112017007942A2 BR 112017007942 A2 BR112017007942 A2 BR 112017007942A2 BR 112017007942 A BR112017007942 A BR 112017007942A BR 112017007942 A BR112017007942 A BR 112017007942A BR 112017007942 A2 BR112017007942 A2 BR 112017007942A2
Authority
BR
Brazil
Prior art keywords
release systems
release
active compound
yarn
skeins
Prior art date
Application number
BR112017007942A
Other languages
English (en)
Portuguese (pt)
Inventor
Anderson David
Scott Goebel Erik
SCHINDLER Jordan
Original Assignee
Textile Based Delivery Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Textile Based Delivery Inc filed Critical Textile Based Delivery Inc
Publication of BR112017007942A2 publication Critical patent/BR112017007942A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Polymers & Plastics (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Professional, Industrial, Or Sporting Protective Garments (AREA)
BR112017007942A 2014-10-30 2015-10-29 sistemas de liberação BR112017007942A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462072896P 2014-10-30 2014-10-30
PCT/US2015/058059 WO2016069898A1 (en) 2014-10-30 2015-10-29 Delivery systems

Publications (1)

Publication Number Publication Date
BR112017007942A2 true BR112017007942A2 (pt) 2017-12-19

Family

ID=55851473

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017007942A BR112017007942A2 (pt) 2014-10-30 2015-10-29 sistemas de liberação

Country Status (10)

Country Link
US (7) US9669012B2 (enExample)
EP (1) EP3212173A4 (enExample)
JP (1) JP6896625B2 (enExample)
KR (1) KR20170076756A (enExample)
CN (1) CN107205956A (enExample)
AU (1) AU2015339203B2 (enExample)
BR (1) BR112017007942A2 (enExample)
CA (1) CA3003397A1 (enExample)
MX (1) MX2017005399A (enExample)
WO (1) WO2016069898A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9731051B2 (en) * 2013-03-26 2017-08-15 Innovia Llc Pacemaker lead and other medical implant devices
WO2016069898A1 (en) 2014-10-30 2016-05-06 Textile-Based Delivery, Inc. Delivery systems
US11690928B2 (en) * 2017-07-17 2023-07-04 Peter Rigg Fragrance delivery systems
US20190145029A1 (en) * 2017-11-13 2019-05-16 Sq-Peg Llc Warp Yarn of Woven Textiles
DE202019005695U1 (de) 2018-09-18 2021-07-01 Mary Kay, Inc. Pflanzenextrakte zum Reduzieren des Erscheinungsbildes von hyperpigmentierter Haut oder zum Aufhellen der Haut
EP3666939B1 (en) 2018-12-12 2024-10-30 Aladdin Manufacturing Corporation A multifilament bundle of melt spun polymer filaments
MX2022007977A (es) * 2019-12-31 2022-07-05 Wanka Tanka Ltd Formulacion plastica de liberacion prolongada.
US20210259985A1 (en) * 2020-02-20 2021-08-26 WeDoWee, LLC Method of providing cbd oil within polymer fibrous structures for subsequent transfer to a user's skin
IT202000005515A1 (it) * 2020-03-16 2021-09-16 U Earth Biotech Ltd Maschera filtrante perfezionata
CA3181984A1 (en) 2020-06-16 2021-12-23 Anthony CASCIO Systems and methods for producing a bundle of filaments and/or a yarn
CN115697872A (zh) 2020-06-16 2023-02-03 美国阿拉丁制造公司 用于生产长丝束和/或纱线的系统和方法
EP4165240B1 (en) 2020-06-16 2025-10-01 Aladdin Manufacturing Corporation Systems and methods to provide color enhanced yarns
US12186512B2 (en) * 2020-10-26 2025-01-07 Christopher Green Treatment for dry eyes
US12029718B2 (en) 2021-11-09 2024-07-09 Cct Sciences, Llc Process for production of essentially pure delta-9-tetrahydrocannabinol
KR20230154203A (ko) 2021-03-05 2023-11-07 에이치. 비. 풀러, 컴퍼니 무위험 안정제를 갖는 시아노아크릴레이트 조성물
IT202100006290A1 (it) 2021-03-16 2022-09-16 U Earth Biotech Ltd Una maschera facciale indossabile e configurata per filtrare l’aria inalata da un utente
IT202100006284A1 (it) 2021-03-16 2022-09-16 U Earth Biotech Ltd Mezzi di filtraggio di una maschera facciale indossabile
MX2023012467A (es) * 2021-04-23 2023-10-31 Aladdin Mfg Corp Metodo de fabricacion de hilados e hilados obtenidos de esa manera.
WO2022238862A1 (en) * 2021-05-12 2022-11-17 Aladdin Manufacturing Corporation Fibers with active additives technical field
US20220372695A1 (en) * 2021-05-20 2022-11-24 Textile-Based Delivery, Inc. Active agent indicator for textiles
CN114045587B (zh) * 2021-11-10 2022-09-02 武汉纺织大学 基于亲水改性壳聚糖的复合纱线止血材料
US12245644B2 (en) * 2022-04-28 2025-03-11 Tamika MAYES Support garments
CN114959966B (zh) * 2022-07-15 2023-04-18 苏州赛恩环境科技有限公司 一种内注甲醛清除剂的纤维线生产设备及方法

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1814853A (en) 1930-01-13 1931-07-14 Dow Chemical Co Method of purifying methyl salicylate
US2799598A (en) 1951-08-17 1957-07-16 Owens Corning Fiberglass Corp Process of forming coated twisted yarns and woven fabrics and resultant article
US3674901A (en) * 1966-07-26 1972-07-04 Nat Patent Dev Corp Surgical sutures
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3845761A (en) * 1970-06-02 1974-11-05 Alza Corp Intrauterine contraceptive anti-fertility device for the management of reproduction
JPS4840924B1 (enExample) * 1970-09-26 1973-12-04
US3845791A (en) 1970-10-15 1974-11-05 Continental Can Co Universal filling head
BE789524A (fr) * 1971-09-30 1973-01-15 Alza Corp Dispositif de liberation de medicaments
US3948254A (en) 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
GB1412970A (en) * 1974-01-15 1975-11-05 Schering Ag Pharmaceutical preparations containing silicone rubber
US3993072A (en) 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
US3992518A (en) * 1974-10-24 1976-11-16 G. D. Searle & Co. Method for making a microsealed delivery device
US4314557A (en) 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
JPS6072550A (ja) * 1983-09-27 1985-04-24 日東電工株式会社 創傷カバ−剤
US4751133A (en) * 1984-11-13 1988-06-14 Thermedics, Inc. Medical patches and processes for producing same
US4638043A (en) * 1984-11-13 1987-01-20 Thermedics, Inc. Drug release system
US6040251A (en) * 1988-03-14 2000-03-21 Nextec Applications Inc. Garments of barrier webs
US5221722A (en) * 1988-11-28 1993-06-22 The B. F. Goodrich Company Crosslinked polyacrylic acid
EP0395476A3 (en) 1989-04-28 1992-01-08 Ricoh Kyosan Inc. Method and apparatus for the production of ionic cloths for use in ionic dressings
FR2664815B1 (fr) * 1990-07-23 1994-11-04 Adir Systeme matriciel autoadhesif pour la liberation prolongee du piribedil par voie transcutanee.
CA2120359C (en) 1991-10-04 2000-12-26 Tomas Landh Particles, method of preparing said particles and uses thereof
US5353820A (en) * 1992-02-06 1994-10-11 Gillette Canada Inc. Flavored dental cleaning article and method
US5299335A (en) 1993-08-23 1994-04-05 Ivester Philip K Fragrance-releasing pillow and the like
US6103644A (en) * 1993-12-22 2000-08-15 Nordico Marketing Development, Inc. Impregnated matrix and method for making same
US5660848A (en) 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US6254883B1 (en) 1996-01-30 2001-07-03 Novagent Oy Composition for transdermal delivery of drugs
US6638621B2 (en) 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
US6020412A (en) * 1997-12-04 2000-02-01 Mitsubishi Polyester Film, Llc Controlled release coating comprising blend of silicone polymer and adhesion promoter
US5932617A (en) * 1998-02-06 1999-08-03 Woundfast Pharmaceuticals Inc. Wound-treating composition and method
JP2000096443A (ja) * 1998-09-25 2000-04-04 Toray Ind Inc 繊維布帛およびその製造方法
US5965137A (en) 1998-11-16 1999-10-12 Advanced Medical Instruments Insect repellent composition and method for inhibiting the transmission and treatment of symptoms of vector-borne diseases
JP2000212873A (ja) * 1999-01-18 2000-08-02 Nonogawa Shoji Kk 機能性繊維
CN1378445B (zh) * 1999-08-06 2013-02-06 得克萨斯系统大学评议会 药物释放生物可降解纤维植入物
US7033603B2 (en) 1999-08-06 2006-04-25 Board Of Regents The University Of Texas Drug releasing biodegradable fiber for delivery of therapeutics
US6158253A (en) * 1999-09-17 2000-12-12 Knit-Rite, Inc. Seamless, form fitting foot sock
JP2001097839A (ja) * 1999-09-28 2001-04-10 Shiseido Co Ltd 加齢臭抑制繊維および繊維処理剤
DE10085395T1 (de) * 1999-12-27 2002-12-05 Kimberly Clark Co Fasern, die eine kontrollierte Abgabe eines aktiven Mittels zur Verfügung stellen
WO2001094687A2 (en) * 2000-06-02 2001-12-13 Milliken & Company Yarns and fabrics having a wash-durable non-electrically conductive topically applied metal-based finish
WO2002013701A1 (en) * 2000-08-17 2002-02-21 Tyco Healthcare Group Lp Sutures and coatings made from therapeutic absorbable glass
GB0024884D0 (en) 2000-10-11 2000-11-22 Astrazeneca Ab Method
EP1345589B1 (en) 2000-11-29 2007-06-27 Lyotropic Therapeutics, Inc. Solvent systems for pharmaceutical agents
CA2363902C (en) 2000-12-07 2005-07-26 Warner-Lambert Company Process and system for controlled-release drug delivery
KR20040005936A (ko) 2001-04-26 2004-01-16 컨트롤 딜리버리 시스템즈 인코포레이티드 공동약물을 함유하는 서방 약물 전달 시스템
FR2826380B1 (fr) 2001-06-22 2007-03-16 Nathalie Chetboun Procede de traitement anti-acariens et anti-microbien des materiaux textiles par huile naturelle microencapsulee
WO2003000236A1 (en) 2001-06-23 2003-01-03 Lyotropic Therapeutics, Inc Particles with improved solubilization capacity
KR100636403B1 (ko) 2001-10-17 2006-10-19 가부시키가이샤 상기 항균성 복합입자 및 항균성 수지조성물
CA2468780A1 (en) * 2001-12-03 2003-06-12 C.R. Bard, Inc. Microbe-resistant medical device, microbe-resistant polymeric coating and methods for producing same
GB0130608D0 (en) 2001-12-21 2002-02-06 Psimedica Ltd Medical fibres and fabrics
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
WO2003094888A1 (en) 2002-05-07 2003-11-20 Control Delivery Systems, Inc. Processes for forming a drug delivery device
WO2004043435A2 (en) 2002-11-13 2004-05-27 Control Delivery Systems, Inc. Systemic delivery of antiviral agents
JP2004195348A (ja) * 2002-12-18 2004-07-15 Akatsuki Kinzoku Kogyo:Kk 塗工シート加工装置および貼付剤
EP2143481A1 (en) 2003-02-19 2010-01-13 Natrix Separations Inc. Composite materials comprising supported porous gels
MX296137B (es) * 2003-06-30 2012-02-13 Procter & Gamble Tramas de nanofibras recubiertas.
US7713440B2 (en) 2003-10-08 2010-05-11 Lyotropic Therapeutics, Inc. Stabilized uncoated particles of reversed liquid crystalline phase materials
DE102004037752A1 (de) * 2004-08-04 2006-03-16 Cognis Deutschland Gmbh & Co. Kg Ausgerüstete Fasern und textile Flächengebilde
US8048446B2 (en) 2005-05-10 2011-11-01 Drexel University Electrospun blends of natural and synthetic polymer fibers as tissue engineering scaffolds
WO2006127454A2 (en) 2005-05-23 2006-11-30 Appleton Papers Inc. Oil-in-water capsule manufacture process and microcapsules produced by such process
UA85488C2 (ru) 2005-06-03 2009-01-26 Басф Акциенгезелльшафт Инсектицидная композиция, ее применение для нанесения на неживой материал, способ пропитки, пропитанный материал и способ покрытия
CN1883438A (zh) 2005-06-21 2006-12-27 香港理工大学 温度响应性智能面膜及其制备方法
WO2007066339A1 (en) 2005-12-07 2007-06-14 Ramot At Tel Aviv University Ltd. Drug-delivering composite structures
JP5819579B2 (ja) 2006-01-13 2015-11-24 サーモディクス，インコーポレイティド 薬物送達のためのマトリックスを含む微粒子
US8968782B2 (en) 2006-06-28 2015-03-03 Surmodics, Inc. Combination degradable and non-degradable matrices for active agent delivery
JP2008057100A (ja) 2006-08-29 2008-03-13 Mmi-Ipco Llc 感温性且つ感湿性のスマートテキスタイル
KR20090060288A (ko) * 2006-09-08 2009-06-11 알베마를 코포레이션 난연 텍스타일 제품 및 이의 제조 방법
US8277711B2 (en) 2007-03-29 2012-10-02 E I Du Pont De Nemours And Company Production of nanofibers by melt spinning
WO2009067242A2 (en) 2007-11-20 2009-05-28 Imclone Llc Co-crystal of antibody 11f8 fab fragment and egfr extracellular domain and uses thereof
US20090158492A1 (en) 2007-12-21 2009-06-25 Min Yao Quick-drying textile
CN101970560A (zh) * 2008-01-08 2011-02-09 奎克-麦德技术公司 醇可溶性的季铵聚合物消毒剂
CN102573905A (zh) 2008-12-05 2012-07-11 勒帕斯公司 利用抗脂类抗体晶体结构的抗体设计
US20110142898A1 (en) 2009-12-11 2011-06-16 Jerry Fan Devices for treatment of skin disorders
EP2515864A4 (en) 2009-12-23 2013-09-11 Psivida Inc DELAYED RELEASE DELIVERY DEVICES
US9901128B2 (en) * 2009-12-24 2018-02-27 David A. Gray Antimicrobial apparel and fabric and coverings
DK2547332T3 (en) 2010-03-16 2018-12-17 Titan Pharmaceuticals Inc Heterogeneous implantable drug delivery devices
JP2013526906A (ja) 2010-03-31 2013-06-27 エンバイロセント，インコーポレイテッド 嗅覚活性物質のための方法、組成物、および物品
BR112012025581A2 (pt) 2010-04-06 2019-09-24 Allergan Inc implantes de reservatório de liberação sustentada para distribuição de fármaco intracameral
CN102247316B (zh) * 2011-08-16 2013-09-11 上海交通大学 一种控制药物释放的疏水涂层及其制备方法
WO2013033606A1 (en) * 2011-08-31 2013-03-07 The University Of Akron Coated fibers exhibiting beads-on-a-string morphology
EP2753303B1 (en) * 2011-09-09 2018-04-04 Axxia Pharmaceuticals, Llc Silicone coated implants
WO2014031676A1 (en) * 2012-08-20 2014-02-27 O-Ray Pharma, Inc. Process for manufacturing drug delivery formulations
US20140271863A1 (en) 2013-03-14 2014-09-18 Textile-Based Delivery, Inc. Hot washable poly-n-isopropylacrylamide hydrogel delivery systems
JP2016519222A (ja) * 2013-03-15 2016-06-30 アーセナル メディカル， インコーポレイテッド コア−シース繊維ならびにそれを作製するための方法およびそれを使用するための方法
DE102014208253A1 (de) 2014-04-30 2015-11-05 MAHLE Behr GmbH & Co. KG Abgasanlage für ein Kraftfahrzeug
BR112016025045A2 (pt) * 2014-05-30 2017-08-15 Textile Based Delivery Inc sistema de distribuição de fármaco e método de distribuição de um composto biologicamente ativo
WO2016069898A1 (en) 2014-10-30 2016-05-06 Textile-Based Delivery, Inc. Delivery systems

Also Published As

Publication number Publication date
US20230255895A1 (en) 2023-08-17
US10799464B2 (en) 2020-10-13
JP6896625B2 (ja) 2021-06-30
KR20170076756A (ko) 2017-07-04
AU2015339203B2 (en) 2020-12-24
US20190105283A1 (en) 2019-04-11
CN107205956A (zh) 2017-09-26
WO2016069898A1 (en) 2016-05-06
JP2018503598A (ja) 2018-02-08
US20190038568A1 (en) 2019-02-07
EP3212173A1 (en) 2017-09-06
US9669012B2 (en) 2017-06-06
MX2017005399A (es) 2017-07-26
AU2015339203A1 (en) 2017-04-20
US11633366B2 (en) 2023-04-25
US20160120986A1 (en) 2016-05-05
CA3003397A1 (en) 2016-05-06
EP3212173A4 (en) 2018-06-20
US20170231919A1 (en) 2017-08-17
US11690808B2 (en) 2023-07-04
US20200390720A1 (en) 2020-12-17
US20230338301A1 (en) 2023-10-26

Similar Documents

Publication Publication Date Title
BR112017007942A2 (pt) sistemas de liberação
BR112018001561A2 (pt) curativo de ferimento antimicrobiano absorvente e método de preparação do mesmo
SE1651432A1 (sv) Process for providing coating layer comprising microfibrillated cellulose
BR112017027129A2 (pt) dispositivo e método para tratamento de fio em linha
BR112017002505A2 (pt) tecido e tecido compósito resistente a chamas.
SG11201601871QA (en) Vinyl alcohol polymer, thickening agent, stabilizer for emulsion polymerization, stabilizer for suspension polymerization, coating agent, coated article, sizing agent for fibers, sized yarn, and production method of textile
BR112015003894A2 (pt) materiais revestidos com bioflavonoide
BR112014026105A2 (pt) elementos fibrosos que compreendem um polímero sem hidroxila e métodos de fabricação dos mesmos
BR112017016891A2 (pt) métodos de tratamento de um substrato fibroso e substratos fibrosos
BR112016007986A8 (pt) método de formação de um condutor suspenso que tem uma temperatura operacional mais baixa e método de pré-tratar a superfície externa de um condutor sem isolamento para deposição de um revestimento de superfície
BR112015017875A2 (pt) composição de lavagem com alta espumação, licor de lavagem de substrato duro ou de tecido ou pessoal com alta espumação, método de tratamento de um substrato usando um licor de lavagem
MX2016013384A (es) Fibra organica coloreada, tela y prenda, y metodo para la fabricacion de tela.
BR112019005040A2 (pt) aplicação de pridopidina para tratamento de síndrome de rett
EP3527595A4 (en) Isocyanate composition, aqueous dispersion of isocyanate, method of preparation thereof, coating composition and coating film
BR112017020968A2 (pt) agente de purificação de água e método de purificação de água
ZA201707103B (en) Chemical method and system for the manufacture of fibrous yarn
MX2016007579A (es) Mezclas de fibras con propiedades mejoradas para el manejo de la humedad.
MX2015016341A (es) Composicion acuosa.
BR112016026507A2 (pt) tratamento enzimático de têxteis celulósicos
BR112016007175A2 (pt) transportador de guarnição, método para produzir o mesmo e guarnição para processar fibras têxteis
PL3173390T3 (pl) Powierzchniowy substrat tekstylny z występującą przynajmniej częściowo powłoką ogniochronną, sposób jego wytwarzania i jego zastosowanie
GB2554032A (en) Method of Coating
BR112018001626A2 (pt) carbonato de cálcio precipitado, método para fabricação e usos do mesmo
MY186243A (en) Non-woven fabric and process for forming the same
WO2015117195A9 (en) Coated textile and anti-blister sock

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]